PET-CT scans combine structural and functional imaging to detect diseases early. This technology improves diagnosis accuracy ...

That is why amino acid positron emission tomography (amino acid PET) is increasingly being used in research, but also in the care of patients with brain metastases. This imaging technique uses ...

Researchers have made progress against ‘the skull challenge,’ getting through barriers that prohibit ultrasound from imaging ...

More information: Nathalie L. Albert et al, RANO criteria for response assessment of brain metastases based on amino acid PET imaging, Nature Medicine (2025). DOI: 10.1038/s41591-025-03633-7 ...

Tiny brain tumors often hide in plain sight—sometimes no bigger than a grain of rice. These metastases, or secondary cancers that spread from other parts of the body, are especially dangerous.

There is currently no FDA-approved targeted amino acid PET agent for brain cancer imaging available in the US. TLX101-CDx was previously granted Orphan Drug and Fast Track designations by the FDA.

Discover how amino acid PET imaging is reshaping brain metastases care with new global standards that surpass MRI in tumor activity detection. ... How Amino Acid PET Imaging Is Changing Brain Cancer ...